India
· Delayed Price · Currency is INR AstraZeneca Pharma India Company Description
AstraZeneca Pharma India Limited, a biopharmaceutical company, engages in manufacturing, distributing, and marketing of pharmaceutical products in India and internationally.
It manufactures and sells cardiovascular disease, renal, and metabolism medicines under the CRESTOR, Forxiga, BRILINTA, Xigduo, and Seloken XL brand names; oncology medicines under the TAGRISSO, CALQUENCE, Lynparza, ENHERTU, IMFINZI, and Zoladex brand names; rare diseases medicines under the Koselugo brand name; and respiratory medicines under the Symbicort and Fasenra brand names.
The company also offers medicines for diabetes and immunology diseases. It also provides clinical trial services.
The company was incorporated in 1979 and is based in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.
| Country | India |
| Founded | 1979 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 940 |
| CEO | Sanjeev Panchal |
Contact Details
Address: Manyata Embassy Business Park Bengaluru, 560045 India | |
| Phone | 91 80 6774 8000 |
| Website | astrazeneca.in |
Stock Details
| Ticker Symbol | ASTRAZEN |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| ISIN Number | INE203A01020 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Sanjeev Kumar Panchal | MD, Country President and Director |
| Bhavana Agrawal | Whole-Time Director and Chief Financial Officer |
| Pratap Rudra Bhuvanagiri | Legal Counsel |
| Manasa R. | Company Secretary and Compliance Officer |
| Smita Saha | Vice President of Human Resources |
| Ayush Kumar Agarwal | Interim Business Unit Head of Oncology and Director of Commercial Excellence |
| Praveen Akkinepally | Head of Oncology Business Unit |
| Vinay Sharma | Business Unit Head - Rare Disease unit |
| Pankaj S Jain | Legal Head |